A Clinical Trial to Evaluate the Effects of a Plant-Based Liquid Supplement on Metabolic Health and Overall Well-Being

Biocol Labs

Status: Completed

Conditions: Digestive Symptoms; Metabolic Health; Elevated Liver Enzymes

Treatments: Dietary Supplement: Plant-Based Liquid Supplement

Study type: Interventional

Funder types: Industry

Identifiers

NCT07673432

#20758

Details and patient eligibility

About

This single-arm clinical trial will evaluate the effects of a plant-based liquid supplement on metabolic health, digestive health, skin health, and overall well-being. Twenty participants aged 40 to 60 years with elevated alanine transaminase (ALT) or aspartate transaminase (AST) levels will use the supplement daily for 90 days. Participants will complete questionnaires, provide body composition and waist circumference measurements, submit photographs, and undergo blood testing throughout the study. Outcomes include changes in metabolic biomarkers, body composition, digestive symptoms, skin health, and overall well-being.

Enrollment: 20 patients

Sex: All

Ages: 40 to 60 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age 40 to 60 years
• Elevated ALT or AST identified during prescreening blood testing
• Currently experiencing at least two of the following:

Stomach discomfort, Constipation, Diarrhea, Heartburn, Bloating, Gas, Abdominal pain, Skin redness or pimples, Sugar cravings

• Willing to comply with study requirements
• Willing to discontinue supplements or herbal remedies targeting detoxification, digestive health, liver function, or skin health during the study
• Willing to avoid starting new products, medications, or supplements targeting detoxification, digestive health, liver function, or skin health
• Willing to maintain normal diet, sleep patterns, and activity levels
• Generally healthy without uncontrolled chronic disease
• Resides in the United States
• Not participating in another research study during the study period
• Has access to a study partner to take study photographs

Exclusion criteria

• Severe digestive disorders including acid reflux, IBS, IBD, Crohn's disease, or gastrointestinal tract surgeries
• Liver disease
• Known allergy or hypersensitivity to study product ingredients Chronic conditions that would interfere with study participation, including oncological or psychiatric disorders
• Known severe allergic reactions
• Pregnant, breastfeeding, or attempting to conceive
• Unwilling to follow study procedures
• Stopped hormonal birth control within the past month
• History of substance abuse
• Use of prescription diabetes medications, including GLP-1 receptor agonists such as Ozempic, Wegovy, or Mounjaro

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

20 participants in 1 patient group

Plant-Based Liquid Supplement

Experimental group

Description:

Participants will consume one ampule of the study product diluted in approximately 8 ounces of water before the first meal of the day throughout the study period.

Treatment:

Dietary Supplement: Plant-Based Liquid Supplement